(Q38875419)

English

Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes

scientific article published on 22 October 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 September 2017

Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes (English)

1 reference

Europe PubMed Central

7 September 2017

0 references

(RS)-eflornithine

0 references

African trypanosomiasis

0 references

Gerardo Priotto

4

object named as

Gerardo Priotto

0 references

François Chappuis

3

object named as

François Chappuis

1 reference

Europe PubMed Central

7 September 2017

author name string

Manica Balasegaram

1

1 reference

Europe PubMed Central

7 September 2017

Heather Young

2

1 reference

Europe PubMed Central

7 September 2017

Gerardo Priotto

4

1 reference

Europe PubMed Central

7 September 2017

Marie-Eve Raguenaud

5

1 reference

Europe PubMed Central

7 September 2017

Francesco Checchi

6

1 reference

Europe PubMed Central

7 September 2017

publication date

22 October 2008

1 reference

Europe PubMed Central

7 September 2017

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

7 September 2017

103

1 reference

Europe PubMed Central

7 September 2017

3

1 reference

Europe PubMed Central

7 September 2017

280-290

1 reference

Europe PubMed Central

7 September 2017

Eliminating human African trypanosomiasis: where do we stand and what comes next?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

21 January 2018

Chemotherapy of human African trypanosomiasis: current and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

21 January 2018

Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

21 January 2018

Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

21 January 2018

The phenomenon of treatment failures in Human African Trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

21 January 2018

The situation of sleeping sickness in Angola: a calamity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

21 January 2018

Trypanosomiasis relapse after melarsoprol therapy, Democratic Republic of Congo, 1982-2001.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

21 January 2018

The risk factors for relapse among patients with African trypanosomiasis in Daloa, Cote d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

21 January 2018

Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

21 January 2018

Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

21 January 2018

Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

21 January 2018

Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

21 January 2018

Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

21 January 2018

Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

21 January 2018

Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

21 January 2018

Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

21 January 2018

Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

21 January 2018

Eflornithine for the treatment of human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

7 January 2021

Eflornithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

7 January 2021

The impact of human immunodeficiency virus infection on the epidemiology and treatment of Trypanosoma brucei gambiense sleeping sickness in Nioki, Zaire

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.09.005

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.TRSTMH.2008.09.005

1 reference

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38875419&oldid=1792938790"